LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design 事件

LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design arXiv:2605.25250v1 Announce Type: new Abstract: Lipid nanoparticles (LNPs) are among the most clinically mature platforms for nucleic acid delivery, yet designing lipids that are both effective and biologically safe remains a major bottleneck. In practical screening, toxicity is a decision-level constraint: if a lipid is toxic, its efficiency prediction is clinically irrelevant. We propose LipoAgent, a safety-aware multi-agent